216
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

The Use of Neuroimaging to Predict Treatment Response for Neurosurgical Interventions for Treatment-Refractory Major Depression and Obsessive-Compulsive Disorder

, BSc & , MD, MSc
Pages 155-161 | Received 28 Sep 2010, Accepted 18 Nov 2010, Published online: 01 Jun 2011

REFERENCES

  • Greenberg BD, Rauch SL, Haber SN. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2009;35:1–20.
  • Angst J. Epidemiology of depression. Psychopharmacology (Berl) 1992;106 suppl:S71–4.
  • Dougherty DD, Baer L, Cosgrove GR, Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry 2002;159:269–75.
  • Shields DC, Asaad W, Eskandar EN, Prospective assessment of stereotactic ablative surgery for intractable major depression. Biol Psychiatry 2008;64:449–54.
  • Mayberg HS, Lozano AM, VoonV, Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651– 60.
  • Malone DA, Dougherty DD, Rezai AR, Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009;65:267–75.
  • Schlaepfer TE, Cohen MX, Frick C, Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008;33:368–77.
  • Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder a PET symptom provocation study. Neuropsychopharmacology 2002;27:782–91.
  • Speer AM, Benson BE, Kimbrell TK, Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. J Affect Disord 2009;115:386–94.
  • Little JT, Ketter TA, Kimbrell TA, Venflaxin or buproprion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol Bull 1996;32:629–63.
  • Mayberg HS, Brannan SK, Mahurin RK, Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8:1057–61.
  • Brody AL, Saxena S, Schwartz JM, FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 1998;84:1–6.
  • Wu J, Buchsbaum MS, Gillin JC, Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999;156:1149–58.
  • Videbach P. PET measurements of brain glucose metabolism and blood floow in major depressive disorder: a critical review. Acta Psychiatr Scand 2001;101:11–20.
  • Davidson RJ. Anxiety and affective style: role of the prefrontal cortex and amygdala. Biol Psychiatry 2002;51:68–80.
  • Dougherty DD, Weiss AP, Cosgrove GR, Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for major depression. J Neurosurg 2003;99:1010–7.
  • Keedwell PA, Drapier D, Surguladze S, Giampietro V. Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. J Affect Disord 2010;120:120–5.
  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71.
  • Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psych 1960;23:56.
  • Endicott J, Spritzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766–71.
  • Goodman WK, Price LH, Rasmussen SA, The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006–11.
  • Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry 1969;3:76–9.
  • Evans KC, Dougherty DD, Pollack MH, Rauch SL. Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry 2006;18:33–42.
  • Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997;9: 471–81.
  • Deckersbach T, Dougherty DD, Rauch SL. Functional imaging of mood and anxiety disorders. J Neuroimaging 2006;16:1–10.
  • Jenike MA. An update on obsessive-compulsive disorder. Bull Menninger Clin 2001;65:4–25.
  • Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-99m-HMPAO SPECT. Psychiatry Res 1991;40:247–51.
  • Rosenberg DR, Keshavan MSAE. Bennett research award: toward a neuro-developmental model of obsessive–compulsive disorder. Biol Psychiatry 1998;43:623–40.
  • Davidson RJ, Irwin W, Anderlie MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003;160:64–75.
  • Chen CH, Ridler K, Suckling J, Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007;62:407–14.
  • Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007;164:778–88.
  • Konarski JZ, Kennedy SH, Segal ZV, Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci 2009;34:175–80.
  • Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P. Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 2002;159:1830–40.
  • Kennedy SH, Evans KR, Kruger S, Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001;158:899–905.
  • Drevets WC, Price JL, Bardgett ME, Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortiosol levels. Pharmacol Biochem Behav 2002;71:431–47.
  • Drevets WC, Price JL, Simpson JR, Todd RD, Reich T. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;86:824–7.
  • Hirayasu Y, Shenton ME, Salisbury DF, Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999;156:1091–3.
  • Botteron KN, Raichle ME, Drevets WC, Heath AC, Todd RD. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry 2002;51:342–4.
  • Mayberg HS, Brannan SK, Tekell JL, Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48: 830–43
  • Greicius MD, Flores BH, Menon V, Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 2007;62:429–37.
  • Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys, and humans. Cereb Cortex 2000;10:206–19.
  • Drevets WC, Videen TO, Price JL, A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628–41.
  • Dougherty DD, Rauch SL, Greenberg BD. Pathophysiology of obsessive compulsive disorders. In: Stein DJ, Hollander E, eds. Textbook of anxiety disorders. Washington, DC: American Psychiatric Publishing, 2010.
  • Rauch SL, Dougherty DD, Cosgrove GR, Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 2001;50:659–67.
  • Rauch SL, Savage CR, Brown HD. A PET investigation of implicit and explicit sequence learning. Hum Brain Mapp 1995;3:271–86.
  • Rauch SL, Whalen PJ, Savage CR, Striatal recruitment during implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapp 1997;5:124–32.
  • Saxena S, Brody AL, Ho MC, Zohrabi N, Maidment KM, Baxter LK Jr. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disoder versus major depression. Am J Psychiatry 2003;160:522– 32.
  • Swedo SE, Pietrini P, Leonard HL, Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 1992;49:690–4.
  • Van Laere K, Nuttin B, Gabriels L, Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 2006;47: 740–7.
  • Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol 2002;363:615–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.